
Felix Biotechnology YC 申请
Felix Biotechnology 在 Winter 2020 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。
- YC 批次
- Winter 2020
- 行业
- HealthcareDrug Discovery and Delivery
- 团队规模
- 6
- 状态
- Inactive
- 已发布
- 2020
创始人
Robert McBrideFounder
Vivek MutalikFounder
Paul TurnerFounder
Felix Biotechnology 做什么
We are building the first end-to-end digital viral design platform to protect the world against the coming threat of antimicrobial resistance.
Felix Biotechnology 的 YC 申请,重建版
Y Combinator 申请
Felix Biotechnology,Winter 2020 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Felix Biotechnology
We're creating programmable therapies
We are building the first end-to-end digital viral design platform to develop programmable viral therapies targeting antimicrobial resistance. Our platform designs and engineers therapeutic viruses to protect against resistant infections, addressing a growing global health threat by enabling faster, scalable drug discovery and delivery.
We are based in San Francisco, CA, USA, and plan to remain here after YC.
San Francisco is a hub for biotech and software talent and close to investors interested in healthcare innovation. Being here lets us recruit experts and collaborate where similar startups and research institutions operate.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。
常见问题解答
这是 Felix Biotechnology 的真实 YC 申请吗?
不是。Y Combinator 对提交的申请保密。这是重建版:使用 Felix Biotechnology 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 Felix Biotechnology 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。
Felix Biotechnology 是哪个 YC 批次的?
Felix Biotechnology 是 Y Combinator Winter 2020 批次的成员。
谁创立了 Felix Biotechnology?
Felix Biotechnology 由 Robert McBride, Vivek Mutalik, Paul Turner 创立。
Felix Biotechnology 做什么?
We’re creating programmable therapies
如何阅读完整的重建申请?
创建免费的 Round Funded 账户。YC Insights 中包含 Felix Biotechnology 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。